Osteoporosis: Evaluation and treatment
- 37 Downloads
Osteoporosis is a common and costly disease. This article discusses the pathophysiology, diagnosis, and treatment of osteoporosis, including hormone replacement, bisphosphonates, calcitonin, raloxifene, and alternative therapies. As our population ages, osteoporosis will become an even more common disease.
Unable to display preview. Download preview PDF.
- 1.National Osteoporosis Foundation. Osteoporosis: review of the evidence for prevention, diagnosis and treatment and cost-effectiveness analysis. Introduction. Osteoporosis International. 1998:(suppl):S7–S80.Google Scholar
- 4.American Association of Clinical Endocrinologists. Clinical partice guidelines for the prevention and treatment of post-menopausal osteoporosis. Endocr Pract. 1996;2(2):157–171.Google Scholar
- 7.Bone density measurement: a systematic review. J Intern Med. 1997;241((suppl 739):1–60.Google Scholar
- 13.Medicare Program. Medicare coverage of and payment for bone mass measurements. Fed Reg. 1998;63(121):34320–34328.Google Scholar
- 29.Cummings SR, Norton L, Eckert S, et al. Raloxifene reduces the risk of breast cancer and may decrease the risk of endometrial cancer in postmenopausal women: two-year findings from the multiple outcomes of raloxifene evaluation (MORE) trial. [Abstract]. Proceedings of the American Society of Clinical Oncology meeting. 1998:3.Google Scholar
- 31.Jordan VC, Glusman JE, Eckert S, et al. Incident primary breast cancers are reduced by raloxifene: integrated data from multicenter, double-blind, randomized trials in ∼12,000 postmenopausal women. [Abstract]. Proceedings of the American Society of Clinical Oncology meeting. 1998:466.Google Scholar
- 39.Adelercreutz H, Mazur W. Phyto-oestrogens and Western diseases. Ann Med. 1997;29:95–120.Google Scholar